TL
Insider
Thermopylae Holdings Ltd.
10% ownerThermopylae Holdings Ltd. (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 0 sales), most often in AbCellera Biologics Inc. (ABCL). Across 2 priced purchase filings, the average 21-session return was +0.0% from execution and -5.2% from disclosure (delay-adjusted; derived). The largest single filing was $580K of ABCL (177,457 sh × $3.27, as filed), executed Feb 26.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+0.0%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-5.2%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$711K
shares × price, as filed
Last traded
Feb 27
Filed Mar 2
Median ADV $89.1M across their filed names
Open performance→Volume by month
Buys $1.5M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ABCLRecent filings
ABCLPURCHASE
AbCellera Biologics Inc.
View filing →
$131K38,000 sh × $3.44
Exec Feb 27
Filed Mar 2 · 2:16 PM ET ABCLPURCHASE AbCellera Biologics Inc. View filing → $580K
177,457 sh × $3.27
Exec Feb 26
Filed Feb 27 · 4:20 PM ET ABCLPURCHASE AbCellera Biologics Inc. View filing → $742K
343,631 sh × $2.16
Exec Mar 11 2025
Filed Mar 11 2025 · 5:30 PM ET